FDA Investigator Dan G Eisenbrey
Dan G Eisenbrey has inspections in 1 countries as of 13 Sep 2023. Dan G Eisenbrey has collaborated with a combined 1061 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
48
Last Inspection Date:
13 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alexander M Kay,
Ashleigh P Barkans,
Ava M Bowman,
Bryan Baker,
Celia L Silverstein,
Chris A Lane,
Crystal A Harlan,
Dennis G Kawabata,
Dennis R Hudson,
Devon M Shoop,
Dianna D Wardlow Dotter,
Dolores E Price,
Donald W Jehn,
Edward D Harris,
Elizabeth S Howell,
Emal Wahab,
Garrad R Poole,
Gina C Collins,
Gloria A Milster,
Gloria J Baca, MS,
Graham N Giesen,
Ismael Olvera, IV,
James D Eildreth,
James D Hildreth,
Jeffrey J Leclair,
Jessica L Walters Moell,
John A Iwen,
Julian C Hanson,
Kaarin M Slotte,
Katherine L Arnold,
Kathryn A Krentz,
Kelly D Moore,
Kelsey A Hustedt,
Kip J Hanks,
Langer,
Lauren E Swantko,
Lisa M Althar,
Lorna F Jones,
LTJG Bradley E Benasutti,
Marc A Jackson, Jr,
Mark W Babbitt,
Marlene L Davis,
Maximiano Perez,
Mpris Inspector,
Paul M Chefor,
Paulene M Wohlgemuth,
Peter Kessler, PhD,
Rebecca T Davis,
Richard T Riggie,
Rocco C Black,
Savini,
Scott A Nabe,
Sherri N Rohlf, MD,
State Agency,
Stephen R Souza,
Sunitha K Rajaram, PhD,
Timothy S Williamson,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Virgilio F Pacio, CSO,
Young M Yoon
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more